Zhengbo Song

12PUBLICATIONS
40CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 20, 2026
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRASG12D Inhibitor.

Ling Xie, Chunwei Xu, Han Si

|Sep 15, 2025
Inclusion of anti-vascular therapy as a promising option for later-line treatment of malignant pleural mesothelioma: a retrospective study.

Keda Shao, Di Wu, Qian Wang

|Jul 24, 2024
Rechallenge immunotherapy after immune resistance in patients with advanced thymic carcinoma.

Keda Shao, Xiaohong Zeng, Yue Hao

|Jul 24, 2024
The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumors.

Han Si, Xiaoshuang Fu, Yue Hao

|Apr 16, 2024
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations.

Yanhua Wang, Jingwen Wei, Manyi Xu

|Apr 16, 2024
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment.

Ke Wang, Manyi Xu, Yanhua Wang

Pageof 2

Frequent Collaborators

4 joint publications

Yue Hao

1 joint publications

Wenxian Wang

1 joint publications

Jingwen Wei

1 joint publications

Zheng Shi